HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents.

AbstractCONCLUSION:
Imaging of the endolymphatic space was possible in most cases after administering a standard dose of gadolinium (Gd) by using heavily T2-weighted 3D fluid-attenuated inversion recovery (hT(2)W-3D-FLAIR) magnetic resonance imaging (MRI).
OBJECTIVES:
The aim of this study was to characterize the contrast enhancement in the inner ear after intravenous injection of Gd and to compare the signal intensity after a double dose or standard dose of Gd.
METHODS:
We injected a standard dose of gadodiamide hydrate (DTPA-BMA) or a double dose of gadoteridol (HP-DO3A) intravenously in patients affected by Meniere's disease and performed hT(2)W-3D-FLAIR 3 T MRI. Contrast enhancement of the basal turn of the cochlea was evaluated semiquantitatively.
RESULTS:
Endolymphatic hydrops was observed in the cochlea and vestibule of the affected ears of patients with Meniere's disease in both the double-dose group and the standard-dose group.
AuthorsHirokazu Suzuki, Masaaki Teranishi, Michihiko Sone, Masahiro Yamazaki, Shinji Naganawa, Tsutomu Nakashima
JournalActa oto-laryngologica (Acta Otolaryngol) Vol. 131 Issue 10 Pg. 1025-31 (Oct 2011) ISSN: 1651-2251 [Electronic] England
PMID21732744 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
  • Heterocyclic Compounds
  • Organometallic Compounds
  • gadoteridol
  • gadodiamide
  • Gadolinium
  • Gadolinium DTPA
Topics
  • Adult
  • Contrast Media (administration & dosage)
  • Female
  • Gadolinium (administration & dosage)
  • Gadolinium DTPA (administration & dosage)
  • Heterocyclic Compounds (administration & dosage)
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Male
  • Meniere Disease (pathology)
  • Middle Aged
  • Organometallic Compounds (administration & dosage)
  • Perilymph
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: